Medical Device News Magazine

Revolutionary Breakthrough: New Antimicrobial Wound Dressings Unveiled at EWMA 2024

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Contributing to this year’s theme at the annual EWMA Conference, ‘Collaborative and Sustainable Wound Care’, experts from Avery Dennison Medical and Polaroid Therapeutics will lead an insightful discussion. Discover how partnership can bring a unique approach to antimicrobial wound dressings.

antimicrobial wound dressings

Polaroid Therapeutics

The 20-minute session explores the synergy of Polaroid Therapeutics’ cutting-edge technology in the development of antimicrobial compounds and Avery Dennison Medical’s renowned expertise in materials science and wound care solutions, resulting in the creation of an innovative antimicrobial platform that elevates patient care and provides solutions to modern global health challenges.

Details of the session:

Title: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

Speakers: Mr Ran Frenkel, CEO, Polaroid Therapeutics; and Dr. Emmett McArdle, Advanced Research and Development Manager at Avery Dennison Medical.

Date and time: Wednesday, May 1st, 2024, from 15:15 to 15:35.

Room: EWMA ARENA (E-Poster Area).

Conference venue: ExCeL London.

All participants to the EWMA Conference can attend this session, no prior registration is needed.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”